{{Rsnum
|rsid=6443930
|Gene=HTR3D
|Chromosome=3
|position=184036506
|Orientation=plus
|GMAF=0.4683
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=HTR3D
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 20.3 | 45.3 | 34.4
| HCB | 20.0 | 51.1 | 28.9
| JPT | 40.9 | 36.4 | 22.7
| YRI | 63.3 | 26.7 | 10.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.0 | 51.1 | 28.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20602613
|Title=Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
}}

{{GET Evidence
|gene=HTR3D
|aa_change=Gly36Ala
|aa_change_short=G36A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6443930
|overall_frequency_n=73
|overall_frequency_d=128
|overall_frequency=0.570312
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=60
|n_articles=0
|n_articles_annotated=0
|nblosum100=1
|autoscore=0
|webscore=N
}}

{{on chip | HumanOmni1Quad}}